• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

    3.700 +0.010 (+0.27%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Larimar Therapeutics, Inc. - Common Stock

    News headline image
    Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
    From The Rosen Law Firm, P.A.
    Via Business Wire
    Larimar Therapeutics Inc. (NASDAQ: LRMR) Leading the Way in Tuesday Trading Based on Percentage Gain
    Via Investor Brand Network
    News headline image
    Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
    From DJS Law Group
    Via Business Wire
    News headline image
    LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Alert: Investigation over Potential Wrongdoing ↗
    San Diego, CA -- (SBWIRE) -- 05/02/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Larimar Therapeutics, Inc. 
    Via SBWire
    News headline image
    Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Notice: Investigation over Possible Violations of Securities Laws ↗
    San Diego, CA -- (SBWIRE) -- 03/02/2022 -- Larimar Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    News headline image
    Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    News headline image
    Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.